 |
인쇄하기
취소
|
Domestic pharmaceutical industry likely to find momentum in third quarter
Korean pharmaceutical industry is expected to gain momentum in the third quarter of this year due to favorable internal factors, said a local analyst in a pharmaceutical report.
The report said that investors will be greatly encouraged by the following positive prospects:
- A flurry of first generic launchings (4 generics for Pfizer's Norvasc and 31 generics for Handok Pharm's Amaryl);
...
The report said that investors will be greatly encouraged by the following positive prospects:
- A flurry of first generic launchings (4 generics for Pfizer's Norvasc and 31 generics for Handok Pharm's Amaryl);
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.